An antisense oligonucleotide to target the RAAS
- PMID: 34040182
- DOI: 10.1038/s41569-021-00574-9
An antisense oligonucleotide to target the RAAS
Comment on
-
Antisense Inhibition of Angiotensinogen With IONIS-AGT-LRx: Results of Phase 1 and Phase 2 Studies.JACC Basic Transl Sci. 2021 May 3;6(6):485-496. doi: 10.1016/j.jacbts.2021.04.004. eCollection 2021 Jun. JACC Basic Transl Sci. 2021. PMID: 34222719 Free PMC article.
References
Original article
-
- Morgan, E. et al. Antisense inhibition of angiotensinogen with IONIS-AGT-LRx: results of phase 1 and phase 2 studies. JACC Basic Transl. Sci. https://doi.org/10.1016/j.jacbts.2021.04.004 (2021) - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
